Innovative Health Initiative

Summary

IHI JU is based on the idea that interdisciplinary and cross-sector collaboration will enable perspective and breakthrough innovations in healthcare, including the pharmaceutical industry but also new fields such as biopharmaceuticals, medical technologies and biotechnologies.

Programme Description

The scientific priorities will focus on cross-sectoral approaches, methods, and tools to facilitate the creation of new products and  services to prevent, intercept, diagnose, treat, and manage diseases and foster recovery more efficiently in various disease areas focusing on unmet public health needs. 

A systems approach to health care (prevention, rehabilitation, not only care for acute /chronic conditions), and design of healthy environment, should be fostered. The scope of the scientific priorities may also cover activities which, while not focused on individual disease areas, have the potential to generate results of transformational nature on innovation processes in healthcare.
The scientific priorities reflect IHI JU’s objectives which focus on the pre-competitive area, thereby creating a safe space for efficient collaboration between companies active in different health technologies. The objectives are not aimed at delivering products or services directly with healthcare systems or onto the market as such.

  • Objective 1 addresses the challenge of unravelling causal factors of disease that are still poorly understood, such as the interplay between genetic and environmental factors
  • Objective 2 addresses one or more of the barriers for the development of new types of products or services in the health domain that integrate diverse components (such as diagnostics, medicinal products, medical devices, wearables, treatment monitoring, digital solutions).
  • Objective 3, which addresses patient-centricity of innovations and the challenge of effectively engaging with all relevant health care actors (patients and civil society, health care professionals, health care providers, regulators, health technology assessment bodies and payers) for the design and development of new and/or integrated health solutions.
  • Objective 4 addresses the challenge that, currently, data in many countries are hard to gather and demonstrate limited interoperability.
  • Objective 5 addresses the methodological challenges in assessing the added value of health interventions based on emerging and converging technologies, which can only be partially addressed with current available tools and methods.

Total Budget

€ 9,280,000

Thematic Categories

  • Education and training
  • Health
  • Research, Technological Development and Innovation

Eligibility for Participation

  • Associations
  • Central Government
  • Large Enterprises
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • Semi-governmental organisations
  • Services Providers
  • State-owned Enterprises
  • Training Centres

Call Opening Date

01/01/2021

Call Closing Date

31/12/2027

EU Contact Point

All questions regarding JU JU invitations should be directed to infodesk@ihi.europa.eu.

Programme/Sub-programme/Plan Calls
  • Setting up a harmonised methodology to promote uptake of early feasibility studies for clinical and innovation excellence in the European Union

    Closed

    Code: 23705 | Identifier Code: HORIZON-JU-IHI-2022-02-02 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    This topic seeks to develop and validate a methodology for EFS that is compliant with EU regulations, including a working methodology, easily accessible online, with information on how to undertake such studies, the process and requirements to follow and fulfil.
    It also aims to bring together the relevant stakeholders that could have an interest in EFS and to facilitate use-cases where technologies would run the newly developed EFS methodological framework in order to test it and recommend any adjustments to be made to the methodology.

  • Cardiovascular diseases - improved prediction, prevention, diagnosis, and monitoring

    Closed

    Code: 23700 | Identifier Code: HORIZON-JU-IHI-2022-02-01 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    The overall aim of the project is to provide tools for the earlier diagnosis of atherosclerosis and heart failure as well as earlier identification of patients at risk. This includes biomarker or predictive algorithms to assess changes in risk and stratify patients according to individual responses to therapeutic intervention.

  • Next generation imaging and image-guided diagnosis and therapy for cancer

    Closed

    Code: 23698 | Identifier Code: HORIZON-JU-IHI-2022-01-02 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    The specific challenge to be solved by this call topic is to provide early evidence of improved cancer patient care when using next-generation imaging technologies and image-guided solutions as part of combined cancer therapies. An optimised image-based care path from early diagnosis and screening to treatment and follow-up is essential to improve the outcome of cancer patients and help optimise clinical workflows and cancer patients’ journey.

  • Access and integration of heterogeneous health data for improved healthcare in disease areas of high unmet public health need

    Closed

    Code: 23696 | Identifier Code: HORIZON-JU-IHI-2022-01-04 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    This topic aims to provide a scalable platform for the seamless integration or linkage of these diverse data at scale, and develop tools to allow the data to be used in clinical care, patient self-management and research in disease areas of high unmet public health.

  • Personalised oncology: innovative people centred, multi-modal therapies against cancer

    Closed

    Code: 23688 | Identifier Code: HORIZON-JU-IHI-2022-01-03 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    The aim of this call topic is biomarker-guided multi-modal precision oncology based on imaging, phenotype, genomics, in vitro diagnostics, co-morbidities, clinical and real-world data.

  • An innovative decision-support system for improved care pathways for patients with neurodegenerative diseases and comorbidities

    Closed

    Code: 23685 | Identifier Code: HORIZON-JU-IHI-2022-01-01 | Programme name: Innovative Health Initiative | Start submission calls: 28/06/2022 | End submission calls: 20/09/2022

    The primary objective of this topic is to develop a decision-support system to enhance medical decisions with targeted clinical knowledge, patient information, and other health information for a more holistic (better integrating diagnosis, treatment and care and breaking silos across specialities) approach to managing and treating patients with a neurodegenerative disease and a comorbid condition, addressing the needs of today, while creating preparedness for a future paradigm-shift in treatment.